NEWS
Huntsman's TPU Elastomers Helping in the Frontline Fight Against COVID-19

FOR IMMEDIATE RELEASE
May 14, 2020
The Woodlands, TX
NYSE: HUN

THE WOODLANDS, Texas – Since the COVID-19 pandemic began, Huntsman has been producing thermoplastic polyurethane (TPU) elastomers for manufacturers of essential medical personal protective equipment (PPE) around the world. Huntsman’s TPUs are being used to produce hospital gowns, face masks, mattress covers, tubes, valves, cable jackets and, notably, powered air purifying respirators (PAPR).

Widely used throughout the world, PAPR is a type of breathing apparatus that provides frontline health care workers a very high level of protection against viruses such as COVID-19. The battery-powered PAPR purifies contaminated air through a filter mounted on a PAPR blower unit that delivers clean air through a lightweight breathing hose into the wearer’s head covering.

BioThane, a manufacturer of coated webbing located in North Ridgeville, Ohio, makes the waist belts that hold the PAPR battery pack in place. Huntsman’s IROGRAN® TPU coats the webbing, ensuring the highly durable belts are easy to thoroughly clean. Additionally, BioThane uses the same TPU-coated webbing to create systems for other patient transfer applications where scrubbable materials are vital.

Ethan Boron, President of BioThane, said: “We have been serving medical and safety markets for decades and sincerely appreciate and thank the frontline workers for their dedication. We are working hard to supply the belting required for these applications to ensure they have access to the PPE they so urgently need.”

Tony Hankins, President of Huntsman’s Polyurethanes business, added: “We are pleased to be helping in the fight against COVID-19 and honored to be a critical supplier to BioThane. This is th e latest effort in a series of initiatives we have undertaken across the world in response to the pandemic, including the donation of our polyurethane systems to manufacture insulation panels for pre-fabricated quarantine hospitals, and to our customers producing spandex for medical PPE, such as masks, protection suits and shoes.”

For more information about BioThane, please contact: Kim Madjar, Director of Sales & Marketing at +1 440-327-0485 x155.

For more information about Huntsman, please contact Joanna Marzec at joanna_marzec@huntsman.com.

IROGRAN® is a registered trademark of Huntsman or an affiliate thereof. All rights reserved.

About Huntsman:
Huntsman Corporation is a publicly traded global manufacturer and marketer of differentiated and specialty chemicals with 2019 revenues of approximately $7 billion. Our chemical products number in the thousands and are sold worldwide to manufacturers serving a broad and diverse range of consumer and industrial end markets. We operate more than 70 manufacturing, R&D and operations facilities in approximately 30 countries and employ approximately 9,000 associates within our four distinct business divisions. For more information about Huntsman, please visit the company's website at www.huntsman.com.

Social Media:
Twitter: www.twitter.com/Huntsman_Corp
Facebook: www.facebook.com/huntsmancorp
LinkedIn: www.linkedin.com/company/huntsman

Forward-Looking Statements:
Certain information in this re lease constitutes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on management's current beliefs and expectations. The forward-looking statements in this release are subject to uncertainty and changes in circumstances and involve risks and uncertainties that may affect the company's operations, markets, products, services, prices and other factors as discussed under the caption "Risk Factors" in the Huntsman companies' filings with the U.S. Securities and Exchange Commission. Significant risks and uncertainties may relate to, but are not limited to, volatile global economic conditions, cyclical and volatile product markets, disruptions in production at manufacturing facilities, reorganization or restructuring of Huntsman’s operations, including any delay of, or other negative developments affecting the ability to implement cost reductions, timing of proposed transactions, and manufacturing optimization improvements in Huntsman businesses and realize anticipated cost savings, and other financial, economic, competitive, environmental, political, legal, regulatory and technological factors. The company assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by applicable laws.

Media:
Gary Chapman
(281) 719-4324